Omiloxetine: Difference between revisions

Latest revision as of 04:02, 13 February 2025

A detailed overview of the antidepressant drug Omiloxetine

Omiloxetine[edit]

Omiloxetine is a pharmaceutical compound that was developed as an antidepressant. It belongs to the class of drugs known as selective serotonin reuptake inhibitors (SSRIs), which are commonly used in the treatment of major depressive disorder and other mood disorders.

Pharmacology[edit]

Omiloxetine functions primarily by inhibiting the reuptake of serotonin in the brain, thereby increasing the availability of this neurotransmitter in the synaptic cleft. This action is believed to contribute to its antidepressant effects, as serotonin is a key neurotransmitter involved in mood regulation.

Chemical Properties[edit]

The chemical structure of Omiloxetine is characterized by its unique arrangement of atoms, which can be seen in the accompanying image. This structure is crucial for its activity as a selective serotonin reuptake inhibitor.

Development and Clinical Trials[edit]

Omiloxetine was developed in the late 20th century as part of efforts to find new treatments for depression. Although it showed promise in early clinical trials, it was never marketed. The reasons for this could include a variety of factors such as efficacy, safety, or commercial considerations.

Mechanism of Action[edit]

As an SSRI, Omiloxetine selectively inhibits the reuptake of serotonin without significantly affecting other neurotransmitters such as norepinephrine or dopamine. This selectivity is thought to reduce the side effects commonly associated with older classes of antidepressants, such as tricyclic antidepressants.

Side Effects[edit]

Like other SSRIs, Omiloxetine may cause side effects, although specific data on its side effect profile is limited due to its lack of commercialization. Common side effects of SSRIs include nausea, headache, sexual dysfunction, and insomnia.

Related pages[edit]

@@ Line 1: / Line 1: @@
-'''Omiloxetine''' is a [[norepinephrine reuptake inhibitor]] that was under development for the treatment of [[depression]] and [[anxiety disorders]] but was never marketed. It was developed by [[Eli Lilly and Company]].
+{{Short description|A detailed overview of the antidepressant drug Omiloxetine}}
-== History ==
+==Omiloxetine==
-Omiloxetine was developed in the 1980s by Eli Lilly and Company, a pharmaceutical company based in the United States. The drug was intended to be a norepinephrine reuptake inhibitor, a type of drug that increases the amount of norepinephrine in the brain by preventing it from being reabsorbed into nerve cells. This type of drug is commonly used to treat conditions such as depression and anxiety disorders.
+[[File:Omiloxetine.svg|thumb|right|Chemical structure of Omiloxetine]]
+Omiloxetine is a pharmaceutical compound that was developed as an [[antidepressant]]. It belongs to the class of drugs known as [[selective serotonin reuptake inhibitors]] (SSRIs), which are commonly used in the treatment of [[major depressive disorder]] and other mood disorders.
-Despite initial promise, omiloxetine was never marketed. The reasons for this are not publicly known, but it is possible that the drug did not meet the necessary safety and efficacy standards in clinical trials.
+===Pharmacology===
+Omiloxetine functions primarily by inhibiting the reuptake of [[serotonin]] in the brain, thereby increasing the availability of this neurotransmitter in the [[synaptic cleft]]. This action is believed to contribute to its antidepressant effects, as serotonin is a key neurotransmitter involved in mood regulation.
-== Pharmacology ==
+===Chemical Properties===
-As a norepinephrine reuptake inhibitor, omiloxetine works by increasing the amount of norepinephrine in the brain. Norepinephrine is a neurotransmitter, a chemical that transmits signals in the brain. It is involved in regulating mood and anxiety.
+The chemical structure of Omiloxetine is characterized by its unique arrangement of atoms, which can be seen in the accompanying image. This structure is crucial for its activity as a selective serotonin reuptake inhibitor.
-By preventing norepinephrine from being reabsorbed into nerve cells, omiloxetine increases the amount of this neurotransmitter available in the brain. This can help to alleviate symptoms of depression and anxiety.
+===Development and Clinical Trials===
+Omiloxetine was developed in the late 20th century as part of efforts to find new treatments for depression. Although it showed promise in early clinical trials, it was never marketed. The reasons for this could include a variety of factors such as efficacy, safety, or commercial considerations.
-== See also ==
+===Mechanism of Action===
-* [[Norepinephrine reuptake inhibitor]]
+As an SSRI, Omiloxetine selectively inhibits the reuptake of serotonin without significantly affecting other neurotransmitters such as [[norepinephrine]] or [[dopamine]]. This selectivity is thought to reduce the side effects commonly associated with older classes of antidepressants, such as [[tricyclic antidepressants]].
-* [[Depression]]
-* [[Anxiety disorder]]
-* [[Eli Lilly and Company]]
-[[Category:Drugs]]
+===Side Effects===
-[[Category:Depression]]
+Like other SSRIs, Omiloxetine may cause side effects, although specific data on its side effect profile is limited due to its lack of commercialization. Common side effects of SSRIs include [[nausea]], [[headache]], [[sexual dysfunction]], and [[insomnia]].
-[[Category:Anxiety disorders]]
-[[Category:Eli Lilly and Company]]
-{{stub}}
+==Related pages==
+* [[Selective serotonin reuptake inhibitor]]
+* [[Major depressive disorder]]
+* [[Serotonin]]
+* [[Antidepressant]]
+[[Category:Antidepressants]]
+[[Category:Selective serotonin reuptake inhibitors]]